OBJECTIVE Although non-toxic diffuse goitre is a common disorder, litt
le is known of the clinical course of patients. We therefore decided t
o investigate the long-term clinical outcome of patients with non-toxi
c diffuse goitre. DESIGN A retrospective study. PATIENTS Of 850 patien
ts with non-toxic diffuse goitre who met our criteria and were seen in
our thyroid clinic between 1977 and 1985, 108 who had been followed f
or from 5 to 14 years (mean 8 years) were entered in this study. All p
atients fulfilled our criteria having soft diffuse goitres, normal ser
um TSH and T4 concentrations, and undetectable antithyroglobulin and a
ntithyroid microsomal antibodies. MEASUREMENTS A family history of thy
roid disease was obtained and the occurrence of Graves' ophthalmopathy
was noted. Serum TSH and T4 concentrations, and anti-thyroglobulin an
d antithyroid microsomal antibodies were measured during the follow-up
period. Thyroidal radioactive iodine uptake (RAIU), serum free T4 and
free T3 concentrations, and TSH binding inhibitory immunoglobulin (TB
II) activities were determined in all patients who were subsequently f
ound to have abnormal serum TSH or T4 concentrations or signs of Grave
s' ophthalmopathy. RESULTS Thirty-six of the 108 patients (33%) had a
family history of autoimmune thyroid disease. Elevated serum T4 or fre
e T4 concentrations and depressed serum TSH concentrations were found
in six patients during the follow-up period. Hyperthyroid Graves' dise
ase was diagnosed in four of the six patients, subacute thyroiditis in
one, and transient post-partum thyrotoxicosis in one. Hypothyroidism
was found in one patient who was diagnosed as having transient post-pa
rtum hypothyroidism. Euthyroid Graves' disease was diagnosed in one pa
tient. Furthermore, six of these eight patients had a family history o
f autoimmune thyroid disease in first-degree relatives. CONCLUSION Dur
ing a prolonged follow-up period of patients with non-toxic diff use g
oitre, Graves' disease was found in five of 108 patients (four hyperth
yroid Graves' and one euthyroid Graves'), post-partum thyroid dysfunct
ion in two, and subacute thyroiditis in one. Six of these eight patien
ts had a family history of autoimmune thyroid disease in first-degree
relatives. Long-term follow-up is necessary for patients with non-toxi
c diffuse goitre, especially those who have a family history of autoim
mune thyroid disease.